◆ TICKERBASEOpen interactive view →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocksB › BLLN

BillionToOne, Inc. Class A Common Stock (BLLN) Financial History

20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

HEALTHCARE · DIAGNOSTICS & RESEARCH · DATA UPDATED 2026-08-22

BillionToOne, Inc. Class A Common Stock (BLLN) operates in the DIAGNOSTICS & RESEARCH industry and is headquartered in Menlo Park, United States with about 713 employees. Its market capitalization is roughly $5 billion. In the fiscal year ended 2025-12-31, BLLN reported $305M in revenue and $7M in net income.

BillionToOne, Inc., a precision diagnostics company, quantifies biology to create molecular diagnostics. The company provides molecular counting platform, which is designed to detect and measure DNA molecules at the single-count level to help enhance disease detection.

Interactive charts & full statements → Open the BLLN valuation workbench →

BLLN Revenue & Earnings History — Annual Income Statement

Income statementTTM → 2026-06-302025-12-312024-12-312023-12-31
Total Revenue$397M$305M$153M$72M
Gross Profit$283M$208M$81M$17M
Gross Margin %71.3%68.3%53.0%24.1%
Operating Income (EBIT)$43M$16M($47M)($69M)
Operating Margin %10.9%5.2%-30.9%-96.9%
Net Income$34M$7M($42M)($83M)
Net Margin %8.4%2.4%-27.2%-115.3%
EBITDA$50M$20M($27M)($73M)
Earnings Per Share (EPS)$0.65$0.16$-0.93$-1.85
Shares Outstanding (M)54M46M45M45M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLLN Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Total Revenue$109M$108M$96M$84M$67M$59M$45M$38M
Gross Profit$77M$79M$69M$58M$43M$38M$26M$20M
Gross Margin %70.5%73.0%71.4%69.9%65.3%64.4%57.1%52.6%
Operating Income (EBIT)$6M$18M$10M$10M($2M)($2M)($12M)($13M)
Operating Margin %5.0%16.4%10.8%11.5%-2.4%-3.9%-25.9%-32.9%
Net Income$8M$18M$6M$2M$0M($4M)($11M)($15M)
Net Margin %7.4%16.6%6.2%1.8%-0.4%-6.8%-25.5%-38.8%
EBITDA$11M$22M$9M$9M$2M($2M)($10M)($13M)
Earnings Per Share (EPS)$0.15$0.34$0.13$0.03$-0.01$-0.09$-0.26$-0.33
Shares Outstanding (M)54M53M46M45M45M45M45M45M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLLN Free Cash Flow History

Cash flowTTM → 2026-06-302025-12-312024-12-312023-12-31
Cash from Operations (CFO)$45M$25M($41M)($54M)
Capital Expenditures (CapEx)$12M$9M$5M$6M
Free Cash Flow (FCF)$33M$16M($47M)($60M)
FCF Margin %8.3%5.1%-30.7%-83.4%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLLN Quarterly Free Cash Flow — Last 8 Quarters

Quarterly cash flow2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-30
Cash from Operations (CFO)$9M$15M$11M$10M$2M$3M($8M)($10M)
Capital Expenditures (CapEx)$4M$4M$2M$2M$3M$2M$2M$2M
Free Cash Flow (FCF)$5M$11M$9M$8M($1M)$0M($11M)($11M)
FCF Margin %4.7%10.1%9.6%9.4%-1.1%0.5%-23.4%-29.5%

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

BLLN Balance Sheet History

Balance sheet2026-06-302025-12-312024-12-312023-12-31
Total Assets$730M$633M$302M$192M
Cash & Cash Equivalents$549M$496M$191M$97M
Total Liabilities$193M$153M$134M$161M
Total Debt (Short + Long-Term)$98M$63M$6M$54M
Total Shareholders' Equity$537M$480M$168M$30M

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive BLLN viewer.

Other Companies in DIAGNOSTICS & RESEARCH

← BLKCAll “B” companiesBLMN →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.